Client News

NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines

ORYX Confirms ParvOryx Mode of Action in Tumor Explant Model

Secarna Pharmaceuticals successfully completes financing round

Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

Atriva Therapeutics Reports Results of ATR-002 Phase I Clinical Trial

InflaRx Reports Third Quarter 2019 Financial & Operating Results

Sterna biologicals to attend international partnering and investor conferences in November

Apogenix AG: Strong Quality of Life Data for Apogenix’ Asunercept Published in Journal of Neuro-Oncology

InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa

InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa